10x Genomics Inc Ordinary Shares - Class A (TXG)

Industry Health Information Services

This stock can be held in an Investment ISA and an Investment Account

Sell

$15.46

Buy

$15.75

arrow-down$-1.08 (-6.53%)

Prices updated at 13 Dec 2025, 00:27 EST

Prices minimum 15 mins delay

Prices in USD

NASDAQ

-1.69%

NASDAQ

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

Sector

Healthcare

Industry

Health Information Services

Chairman

Mr. John R. Stuelpnagel, D.V.M.

CEO

Dr. Serge Saxonov, PhD

Most recent earnings

31 Dec 2024

Fiscal year end

31 Dec 2024

Employees

1,306

Head office

6230 Stoneridge Mall Road

Pleasanton

United States

94588

+1 925 401-7300

investors@10xgenomics.com

Company website

Key personnel

Owner name chevron-l-regular chevron-r-regular	Salary
Mr. Eric S. Whitaker Chief Legal Officer	0.48m
Dr. Randy Wu Vice President, Intellectual Property and Litigation	-
Mr. John R. Stuelpnagel, D.V.M. Chairman of the Board	0.13m
Ms. Kimberly J. Popovits Independent Director	0.07m
Mr. Alan V. Mateo Independent Director	0.03m
Dr. Shehnaaz Suliman, M.D. Independent Director	0.07m
Dr. Serge Saxonov, PhD Chief Executive Officer and Director	0.63m
Dr. Benjamin J. Hindson, PhD Director, Chief Scientific Officer and President	0.49m
Mr. Sridhar Kosaraju Independent Director	0.08m
Mr. Adam S. Taich Chief Financial Officer and Principal Accounting Officer	0.19m
Dr. Sarah A. Teichmann Independent Director	0.03m

Top 5 shareholders

Owner name chevron-l-regular chevron-r-regular	No. of shares
Vanguard Group Inc	12,440,060
ARK Investment Management LLC	11,887,396
Vanguard Group Inc. ( Junked)	10,972,930
BlackRock Inc	9,460,109
FMR Inc	8,458,001

Director dealings

Date chevron-l-regular chevron-r-regular	Action
23 Dec 2024	-
23 Dec 2024	-
22 Nov 2024	-
21 Nov 2024	-
22 Nov 2024	-
14 Nov 2024	-
23 Oct 2024	-
17 Mar 2025	-
30 Aug 2024	-
22 Aug 2024	-
22 Aug 2024	-
22 Aug 2024	-
31 Jul 2024	-
11 Jun 2024	-
11 Jun 2024	-
11 Jun 2024	-
11 Jun 2024	-
29 May 2024	-
22 May 2024	-
22 May 2024	-

Please note that past performance is not a reliable indicator of future returns.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.